Optibac describes itself as a UK family business and states that it specialises exclusively in probiotics rather than operating as a general supplement company. The brand has received the King’s Award for International Trade and reports donating more than £2 million to charity since its launch. 2

2004 — Foundation

Optibac was established in 2004 by siblings Jalal, Farah and Soraya Janmohamed, with support from their father, who had spent over 35 years working as a community pharmacist. He encouraged the family to develop a business focused on natural health. 3

The operating entity was initially Wren Laboratories Ltd. A core principle established early on was that probiotics should not be treated as interchangeable; instead, the founders prioritised identifying specific strains with specific research behind them. 1

2010s — Expansion

During this period, the company expanded its product range and international distribution. By 2019, Wren Laboratories reported that Optibac products were available through health-food stores and pharmacies across the UK and Ireland, as well as in export markets including the US, China and Vietnam.

The company also received the Queen’s Award for Enterprise, recognising its performance in international trade. This award is now known as the King’s Award for Enterprise.

2024 — 20th Anniversary

Optibac celebrated its 20th anniversary in 2024, marking its growth from a small family venture into a major probiotic brand in the UK and Ireland.

Optibac sells probiotic and live-culture supplements organised around particular strains, uses, and consumer groups. Rather than offering a single generic “probiotic,” the company maintains a portfolio containing different combinations of microorganisms. Its current range includes products for:

• Everyday/general use
• Digestive health
• Women’s intimate/vaginal health
• Pregnancy
• Babies
• Children
• Travel
• People taking antibiotics
• Gut-health support
• Fibre + probiotic supplementation
• Gummies and other convenient formats

Products are available as capsules, powder sachets, liquid drops and gummies.

Every Day

Optibac Every Day is a general-purpose product containing multiple live-culture strains, including:

• Lactobacillus rhamnosus Rosell-11
• Lactobacillus acidophilus/helveticus Rosell-52
• Bifidobacterium longum Rosell-175
• Lactococcus lactis Rosell-1058
• Bifidobacterium breve Rosell-70
• Bifidobacterium bifidum Rosell-71

The company states that the product provides at least 5 billion live microorganisms per daily dose through its expiry date. Higher-strength versions include Every Day EXTRA and Every Day MAX.

For Women

This category focuses on women’s probiotic supplementation. The For Women product contains the combination of:

• Lactobacillus rhamnosus GR-1®
• Lactobacillus reuteri RC-14®

Optibac highlights that this combination has been extensively studied in relation to the vaginal microbiome. This approach distinguishes the brand by associating particular strains with particular applications rather than selling generic high-CFU probiotics.

Bifido & Fibre

Bifido & Fibre combines a probiotic strain with prebiotic fibre. The key probiotic is Bifidobacterium lactis BB-12®. The product also contains fructooligosaccharides (FOS), a type of prebiotic fibre. Optibac states that the product provides 25 billion live microorganisms per sachet.

One Week Flat

This digestive-focused formulation contains a mixture of live cultures and FOS. Current ingredients include:

• Lactococcus lactis Rosell-1058
• Lactobacillus casei Rosell-215
• Lactobacillus acidophilus/helveticus Rosell-52
• Bifidobacterium bifidum Rosell-71

Babies & Children

Optibac offers formulations specifically intended for younger consumers. A notable strain used is Bifidobacterium breve M-16V®, which the company says has been studied in more than 36 clinical trials, including research involving infants and premature babies. The range also includes Kids Gummies and products containing Lactobacillus rhamnosus GG.

Pregnancy

The pregnancy-specific product contains strains such as:

• Lactobacillus rhamnosus HN001
• Lactobacillus acidophilus La-14®
• Bifidobacterium lactis HN019

This product is positioned to address nutritional and microbiome considerations associated with pregnancy and the postnatal period.

Science is central to Optibac’s brand identity. The company emphasises the distinction between a species of microorganism and a specific strain. For example, Lactobacillus rhamnosus is a species, whereas Lactobacillus rhamnosus GR-1® identifies a particular strain. This distinction matters because different strains within the same species can behave differently. Consequently, Optibac argues that choosing a probiotic based solely on total bacterial count (e.g., “20 billion bacteria”) is inadequate without considering the identity and evidence behind the strains.

Clinical Research

Optibac states that its strains undergo both in-vitro research (laboratory testing) and in-vivo/human research (clinical studies). Investigations include whether strains can survive conditions such as stomach acidity and reach the intended site alive.

Prominent strains associated with the brand include:

The company cites hundreds of human clinical trials across its strain portfolio. It notes that evidence for an individual probiotic strain does not automatically establish that every product containing that strain will produce the same clinical result, as factors like dose, formulation, and population studied are critical.

Optibac’s differentiation rests on five key ideas:

1. Strain specificity: The company explicitly publishes the specific strains used in its formulations.
2. Research-led positioning: Emphasis is placed on clinical research and extensively studied strains.
3. Specialist focus: The business is concentrated on probiotics/live cultures, distinct from large companies selling unrelated vitamins and herbal products.
4. Targeted formulations: Products are designed for specific groups and needs (daily, digestive, women, pregnancy, babies, children, travel, antibiotics).
5. Family-business identity: The company continues to highlight its origins as a family business founded by three siblings.

A distinctive part of Optibac’s consumer language is the use of the term “friendly bacteria” alongside “probiotics.” This branding aims to make microbiology less intimidating, presenting products as part of everyday wellness rather than pharmaceutical interventions. The slogan is “Feel Good, Opt for Optibac.”

Products appear in several formats to accommodate different consumers, especially children and those who dislike swallowing capsules:

• Capsules
• Powder sachets
• Liquid drops
• Gummies

Optibac states that its capsules are not enteric-coated; instead, it claims the probiotic strains themselves have been tested for survival through stomach conditions.

Formulation details are emphasised, with ingredient information identifying individual bacterial strains rather than generic “probiotic blends.” Full ingredient lists are published. Depending on the product, formulations may contain probiotic microorganisms, prebiotic fibres (such as FOS), potato starch, maltodextrin, capsule materials, and other stabilising ingredients. Exact ingredients vary substantially between products.

Some products are designed for specific dietary requirements. For example, Every Day is stated to be suitable for vegans and free from added sugar, artificial colourings, or artificial flavourings. However, dietary suitability is product-specific, and consumers should check individual formulations.

Although fundamentally a British brand, Optibac products are sold internationally. Distribution extends across Europe and markets including the United States, China and Vietnam. International trade performance led to Wren Laboratories receiving the Queen’s Award for Enterprise for International Trade (now the King’s Award).

The brand highlights external indicators of reputation, including the King’s Award for International Trade and an “Excellent” rating on Trustpilot. The company also makes marketing claims regarding its status as a leading or trusted friendly-bacteria brand in the UK and Ireland.

Optibac reports donating more than £2 million to charitable causes since launch. It highlights environmental initiatives and support for organisations such as Womankind Worldwide, reinforcing its identity as a socially and environmentally conscious family business.

From a marketing perspective, Optibac occupies a position between consumer wellness and science-led supplementation. Its messaging combines science (clinical trials, named strains), natural health (microbiome, friendly bacteria), family values, specialisation, and premium expertise. This positions Optibac closer to a probiotic specialist than a conventional multivitamin company.

Competitive Identity

In the probiotic market, Optibac distinguishes itself from general supplement companies, supermarket private labels, and pharmaceutical brands by focusing on being a specialist, research-led probiotic/live-culture brand. Its strategy is not primarily price-based but relies on the proposition: “Choose the right, scientifically researched strain for your particular need.”

Strengths

Key strengths identified include:

• Strong specialisation in probiotics
• Clear focus on specific strains
• Extensive emphasis on clinical research
• Broad range covering different ages and life stages
• Multiple dosage formats
• Transparent publication of individual strains and ingredients
• Long operating history dating to 2004
• Strong UK/family-business identity
• International distribution
• Investment in educational content about probiotics

Consumer Considerations

Optibac is a food-supplement brand, not a pharmaceutical company. Consumers should note that:

• “Clinically researched strain” does not guarantee every claimed benefit.
• Research on one strain does not automatically apply to another strain of the same species.
• Higher CFU numbers do not necessarily indicate a better product.
• Probiotic effects depend on the individual, formulation, dose, and health outcome.
• Supplements are not substitutes for medical treatment.
• Suitability during pregnancy, for infants, or alongside medication should be checked with a healthcare professional.

Optibac stresses that different strains have different actions and that probiotics are not a “one size fits all” category.

1. Meet The Optibac Founders, Farah, Jalal and Soraya. – Optibac
2. Official Optibac website
3. About Optibac Probiotics – The Experts In Friendly Bacteria. – Optibac